A. Bisgin Et Al. , "Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients," DIABETES RESEARCH AND CLINICAL PRACTICE , vol.96, no.3, 2012
Bisgin, A. Et Al. 2012. Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients. DIABETES RESEARCH AND CLINICAL PRACTICE , vol.96, no.3 .
Bisgin, A., Yalcin, A. D., & Gorczynski, R. M., (2012). Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients. DIABETES RESEARCH AND CLINICAL PRACTICE , vol.96, no.3.
Bisgin, A., A. D. Yalcin, And R. M. Gorczynski. "Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients," DIABETES RESEARCH AND CLINICAL PRACTICE , vol.96, no.3, 2012
Bisgin, A. Et Al. "Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients." DIABETES RESEARCH AND CLINICAL PRACTICE , vol.96, no.3, 2012
Bisgin, A. Yalcin, A. D. And Gorczynski, R. M. (2012) . "Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients." DIABETES RESEARCH AND CLINICAL PRACTICE , vol.96, no.3.
@article{article, author={A. Bisgin Et Al. }, title={Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients}, journal={DIABETES RESEARCH AND CLINICAL PRACTICE}, year=2012}